Admission to AIM and First Day of Dealings

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

8 December 2014

Constellation Healthcare Technologies, Inc.

("Constellation Healthcare Technologies" or the "Company")

Admission to AIM and First Day of Dealings

Constellation Healthcare Technologies, the healthcare services organisation, announces the admission to trading on the AIM market of the London Stock Exchange plc ("AIM") of its entire issued common share capital, and commencement of dealings, at 8.00am today under the ticker CHT.

Constellation Healthcare Technologies and its subsidiaries (the "Group") provide outsourced revenue cycle management ("RCM"), practice management ("PM") and group purchasing services to the physician market in the United States.

Approximately £9.6 million has been raised for the Group through a placing of 7,128,235 common shares at 135 pence per share. The total number of common shares in issue at Admission is 55,615,056, giving the Company a market capitalisation of approximately £75 million at the placing price.

The net proceeds of the placing receivable by the Company will be applied towards selective acquisitions in line with the Group's strategy, the integration of such acquisitions, and for general working capital purposes.

John Johnston, Chairman of Constellation Healthcare Technologies, said:

"We are pleased that investors have responded positively to the placing, recognising the significant opportunity available to the Company in consolidating a large and highly fragmented market. Amongst other things, AIM provides the ideal platform for M&A, and we look forward to making use of it to help drive growth in the business".

For further information regarding Constellation Healthcare Technologies please call: